Neonatal Screening for Congenital Hypothyroidism in The Netherlands: Cognitive and Motor Outcome at 10 Years of Age
Open accessThe DOI matches its Crossref record; 14 of the 15 references it cites were found in a registry or an index.
Abstract
Context: Patients with thyroidal congenital hypothyroidism (CH-T) born in The Netherlands in 1981–1982 showed persistent intellectual and motor deficits during childhood and adulthood, despite initiation of T4 supplementation at a median age of 28 d after birth. Objective: The present study examined whether advancement of treatment initiation to 20 d had resulted in improved cognitive and motor outcome. Design/Setting/Patients: In 82 Dutch CH-T patients, born in 1992 to 1993 and treated at a median age of 20 d (mean, 22 d; range, 2–73 d), cognitive and motor outcome was assessed (mean age, 10.5 yr; range, 9.6–11.4 yr). Severity of CH-T was classified according to pretreatment free T4 concentration. Main Outcome Measure: Cognitive and motor outcome of the 1992–1993 cohort in comparison to the 1981 to 1982 cohort was the main outcome measure. Results: Patients with severe CH-T had lower full-scale (93.7), verbal (94.9), and performance (93.9) IQ scores than the normative population (P < 0.05), whereas IQ scores of patients with moderate and mild CH-T were comparable to those of the normative population. In all three severity subgroups, significant motor problems were observed, most pronounced in the severe CH-T group. No correlations were found between starting day of treatment and IQ or motor outcome. Conclusions: Essentially, findings from the 1992–1993 cohort were similar to those of the 1981–1982 cohort. Apparently, advancing initiation of T4 supplementation from 28 to 20 d after birth did not result in improved cognitive or motor outcome in CH-T patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the vast majority of early and adequately treated children with CH, neurodevelopmental and school outcomes level are normal (90,91,159–161), and intellectual disability—defined as an IQ <70—has virtually disappeared (162).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Haddow, J. E., Palomaki, G. E., Allan, W. C., Williams, J. R., Knight, G. J., Gagnon, J., O'Heir, C. E., Mitchell, M. L., Hermos, R. J., Waisbren, S. E., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410801 · Cited by 2,558
Bongers-Schokking, J. J., Koot, H. M., Wiersma, D., Verkerk, P. H., & de Muinck Keizer-Schrama, S. M. P. F. (2000) · The Journal of Pediatrics · doi:10.1067/mpd.2000.103351 · Cited by 233 · cited 1×
“(4) have shown that in severe CH, a treatment delay of 6 d, in patients receiving an initial T4 dose of 10.”
BackgroundDubuis, J. M. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.1.222 · Cited by 194 · cited 6×
“920 J Clin Endocrinol Metab, March 2007, 92(3):919–924 Kempers et al.”
BackgroundInfluentialSelva, K. A., Harper, A., Downs, A., Blasco, P. A., & LaFranchi, S. H. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.07.024 · Cited by 190 · cited 1×
“(6), considering a mean initial T4 dose of 10.”
BackgroundKooistra, L., Laane, C., Vulsma, T., Schellekens, J. M. H., van der Meere, J. J., & Kalverboer, A. F. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)83178-6 · Cited by 185 · cited 4×
“9 yr) (1) were available for retrospective analysis.”
BackgroundMethodInfluentialSelf-citationBongers-Schokking, J. J., & de Muinck Keizer-Schrama, S. M. P. F. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.09.031 · Cited by 131 · cited 2×
“However, Bongers-Schokking and de Muinck Keizer-Schrama (5), considering a similar dose of 10.”
BackgroundInfluentialSimoneau-Roy, J., Marti, S., Deal, C., Huot, C., Robaey, P., & Van Vliet, G. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.02.021 · Cited by 123 · cited 1×
“1 g/kg d, was normal both at 18 months (3) and 5 yr of age (17).”
BackgroundKempers, M. J. E., van der Sluijs Veer, L., Nijhuis-van der Sanden, M. W. G., Kooistra, L., Wiedijk, B. M., Faber, I., Last, B. F., de Vijlder, J. J. M., Grootenhuis, M. A., & Vulsma, T. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1209 · Cited by 122 · cited 4×
“We found persistent subtle cognitive and motor deficits up to adulthood in these patients, for whom T4 supplementation was initiated at a median age of 28 d after birth (1, 2).”
BackgroundInfluentialSelf-citationManagement of Congenital Hypothyroidism
FISHER, D. A. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-3-523 · Cited by 121
Slaton, D. S., & Nichols, P. J. (1988) · Physical & Occupational Therapy In Pediatrics · doi:10.1080/j006v07n04_07 · Cited by 63
Research works printed but not linked: 3
- Kort W, Compaan EL, Bleichrodt N, Resing WCM, Schittekate M, Bosmans M, Vermeir G, Verhaeghe P 2002 WISC-III, 3rd edition NL. Wechsler D, ed. Handleiding. [Dutch manual] Amsterdam: Harcourt Test Publishers
- Haasen PP, de Bruyn EEJ, Pij YJ, Poortinga YH, Lutje Spelberg HC 1986 Wechsler Intelligence Scale for Children-Revised; Dutch edition. Lisse, The Netherlands: Swets, Zeitlinger
- Kort W, Schittekatte M, Dekker PH, Verhaeghe P, Compaan EL, Bosmans M, Vermeir G 2005 WISC-III, 3rd edition NL. Wechsler D. Handleiding en ver- antwoording [Technical manual] Amsterdam: Harcourt Test Publishers
Cited by
Léger, J., Olivieri, A., Donaldson, M., Torresani, T., Krude, H., van Vliet, G., Polak, M., Butler, G., & on behalf of ESPE-PES-SLEP-JSPE-APEG-APPES-ISPAE, A. T. C. H. C. C. G. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1891 · Cited by 569
van Trotsenburg, P., Stoupa, A., Léger, J., Rohrer, T., Peters, C., Fugazzola, L., Cassio, A., Heinrichs, C., Beauloye, V., Pohlenz, J., et al. (2021) · Thyroid® · doi:10.1089/thy.2020.0333 · Cited by 469
“In the vast majority of early and adequately treated children with CH, neurodevelopmental and school outcomes level are normal (90,91,159–161), and intellectual disability—defined as an IQ <70—has virtually disappeared (162).”
BackgroundPersani, L., Brabant, G., Dattani, M., Bonomi, M., Feldt-Rasmussen, U., Fliers, E., Gruters, A., Maiter, D., Schoenmakers, N., & van Trotsenburg, A. S. P. (2018) · European Thyroid Journal · doi:10.1159/000491388 · Cited by 222
Grosse, S. D., & Van Vliet, G. (2011) · Archives of Disease in Childhood · doi:10.1136/adc.2010.190280 · Cited by 222
“and/or delayed bone maturation at diagnosis, who are at risk for lower cognitive test scores.”
BackgroundLéger, J., Olivieri, A., Donaldson, M., Torresani, T., Krude, H., van Vliet, G., Polak, M., Butler, G., & on behalf of ESPE-PES-SLEP-JSPE-APEG-APPES-ISPAE, A. T. C. H. C. C. G. (2014) · Hormone Research in Paediatrics · doi:10.1159/000358198 · Cited by 208
Congenital Hypothyroidism: Screening and Management
Rose, S. R., Wassner, A. J., Wintergerst, K. A., Jones, N. Y., Hopkin, R. J., Chuang, J., Smith, J. R., Abell, K. B., LAFRANCHI, S. H., Wintergerst, K. A., et al. (2022) · PEDIATRICS · doi:10.1542/peds.2022-060420 · Cited by 129
Mechanisms related to the pathophysiology and management of central hypothyroidism
Yamada, M., & Mori, M. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0995 · Cited by 114
Thyrotropin secretion patterns in health and disease
Roelfsema, F., & Veldhuis, J. D. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1076 · Cited by 113
“In any case, false-negative results should be avoided (165, 166).”
BackgroundCongenital hypothyroidism: insights into pathogenesis and treatment
Cherella, C. E., & Wassner, A. J. (2017) · International Journal of Pediatric Endocrinology · doi:10.1186/s13633-017-0051-0 · Cited by 106
“While few of these patients had the severely low FT4 levels often seen in primary congenital hypothyroidism, their FT4 levels were reduced to a range (5–10 pmol/L) that has been associated with modest deficits at age 10 years [37].”
BackgroundRibault, V., Castanet, M., Bertrand, A.-M., Guibourdenche, J., Vuillard, E., Luton, D., Polak, M., & the French Fetal Goiter Study Group (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2681 · Cited by 89
Albert, B. B., Heather, N., Derraik, J. G. B., Cutfield, W. S., Wouldes, T., Tregurtha, S., Mathai, S., Webster, D., Jefferies, C., Gunn, A. J., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1903 · Cited by 75
“Neurocognitive deficit in childhood has been associated with markers of CHT severity including initial T4 (5, 6, 9) and TSH (9, 11), bone immaturity (9, 12), and etiology (thyroid agenesis) (9, 13) as well as sociodemographic factors such as parental education and rural setting (14).”
BackgroundResultAleksander, P. E., Brückner-Spieler, M., Stoehr, A.-M., Lankes, E., Kühnen, P., Schnabel, D., Ernert, A., Stäblein, W., Craig, M. E., Blankenstein, O., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01937 · Cited by 64
Update on congenital hypothyroidism
Cherella, C. E., & Wassner, A. J. (2020) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000520 · Cited by 61
Álvarez, M., Iglesias Fernández, C., Rodríguez Sánchez, A., Dulín ĺñiguez, E., & Rodríguez Arnao, M. D. (2010) · Hormone Research in Paediatrics · doi:10.1159/000313370 · Cited by 57
Guidelines for Mass Screening of Congenital Hypothyroidism (2014 revision)
Nagasaki, K., Minamitani, K., Anzo, M., Adachi, M., Ishii, T., Onigata, K., Kusuda, S., Harada, S., Horikawa, R., Minagawa, M., et al. (2015) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.24.107 · Cited by 50
A novel therapeutic paradigm to treat congenital hypothyroidism
Mathai, S., Cutfield, W. S., Gunn, A. J., Webster, D., Jefferies, C., Robinson, E., & Hofman, P. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03172.x · Cited by 44
Guidelines for Newborn Screening of Congenital Hypothyroidism (2021 Revision)
Nagasaki, K., Minamitani, K., Nakamura, A., Kobayashi, H., Numakura, C., Itoh, M., Mushimoto, Y., Fujikura, K., Fukushi, M., & Tajima, T. (2022) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.2022-0063 · Cited by 48
van Iersel, L., van Santen, H. M., Potter, B., Li, Z., Conklin, H. M., Zhang, H., Chemaitilly, W., & Merchant, T. E. (2020) · Pediatric Blood & Cancer · doi:10.1002/pbc.28723 · Cited by 33
Neurodevelopment evaluation in children with congenital hypothyroidism by Bayley-III
Kömür, M., Özen, S., Okuyaz, Ç., Makharoblıdze, K., & Erdoğan, S. (2012) · Brain and Development · doi:10.1016/j.braindev.2012.07.003 · Cited by 33
“reported that severity of CH was more determining on long term cognitive and motor functions rather than the treatment initiation time [18,19].”
Congenital hypothyroidism: Screening, diagnosis, management, and outcome
Ahmad, N., Irfan, A., & Saedi, S. A. (2017) · Journal of Clinical Neonatology · doi:10.4103/jcn.jcn_5_17 · Cited by 37
Veer, L. V. D. S., Kempers, M. J. E., Wiedijk, B. M., Last, B. F., Grootenhuis, M. A., & Vulsma, T. (2012) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e3182690727 · Cited by 33
“4 mU/L, and (4) FT4 was >29 pmol/L in combination with TSH<0.”
BackgroundSelf-citationHauri-Hohl, A., Dusoczky, N., Dimitropoulos, A., Leuchter, R. H.-V., Molinari, L., Caflisch, J., Jenni, O. G., & Latal, B. (2011) · Pediatric Research · doi:10.1203/pdr.0b013e3182321128 · Cited by 25
Perri, K., Mori, L. D., Tortora, D., Calevo, M. G., Allegri, A. E. M., Napoli, F., Patti, G., Fava, D. F., Crocco, M., Schiavone, M., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab412 · Cited by 27
Núñez, A., Bedregal, P., Becerra, C., & L., F. G. (2017) · Revista médica de Chile · doi:10.4067/s0034-98872017001201579 · Cited by 40
Rahmani, K., Yarahmadi, S., Etemad, K., Koosha, A., Mehrabi, Y., Aghang, N., & Soori, H. (2016) · Intern J Endocrinol Metab · doi:10.5812/ijem.36080 · Cited by 26
“In this review however we found only one study reporting no correlations between initiation time of treatment and IQ or motor outcomes (22).”
BackgroundDíllí, D., Oguz, S. S., Andıran, N., Dilmen, U., & Büyükkağnıcı, Ü. (2010) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2010.145 · Cited by 23
“001 Length of hospital stay (d) median (min-max) 42 (7-126) 26 (9-72) 0.”
MethodDelvecchio, M., Vigone, M. C., Wasniewska, M., Weber, G., Lapolla, R., Popolo, P. P., Tronconi, G. M., Di Mase, R., De Luca, F., Cavallo, L., et al. (2015) · Italian Journal of Pediatrics · doi:10.1186/s13052-015-0190-y · Cited by 22
“However, even if the neonatal screening programs ensure the prompt initiation of the therapy and the neurodevelopmental outcome can be considered generally normal, some problems in relation to mental outcome are still reported in follow-up studies [17, 18].”
BackgroundQuality of life of young adults with congenital hypothyroidism
Sato, H., Nakamura, N., Harada, S., Kakee, N., & Sasaki, N. (2009) · Pediatrics International · doi:10.1111/j.1442-200x.2008.02686.x · Cited by 22
Bisacchi, N., Bal, M. O., Nardi, L., Bettocchi, I., D'Addabbo, G., Conti, V., Monti, S., D'Alberton, F., Cicognani, A., & Cassio, A. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-0761 · Cited by 21
Congenital Hypothyroidism: Long-Term Experience with Early and High Levothyroxine Dosage
Uyttendaele, M., Lambert, S., Tenoutasse, S., Boros, E., Ziereisen, F., Van Vliet, G., Heinrichs, C., & Brachet, C. (2016) · Hormone Research in Paediatrics · doi:10.1159/000443958 · Cited by 21
Feizi, A., Hashemipour, M., Hovsepian, S., Amirkhani, Z., Kelishadi, R., Yazdi, M., Heydari, K., Sajadi, A., & Amini, M. (2013) · ISRN Endocrinology · doi:10.1155/2013/463939 · Cited by 19
“…Sciences, Isfahan, Iran 2 Endocrinology and Metabolism Research Center and Child Growth and Development Research Center, Isfahan University of Medical Sciences, Isfahan 8174673837, Iran 3 Isfahan University of Medical Sciences, Isfahan, Iran 4Child Growth and Development Research Center, Isfahan…”
BackgroundInfluentialOrmazabal, P., Bastías-Pérez, M., Inestrosa, N. C., & Cisternas, P. (2025) · Pharmaceuticals · doi:10.3390/ph18101527 · Cited by 18
“…and epigenetic diversity; (4) coexisting comorbidities such as type 2 diabetes mellitus, cardiovascular disease, and depression; and (5) sex and hormonal modulations, particularly postmenopausal estrogen loss enhancing resistin and lowering adiponectin, worsening adipokine balance [277–279].”
Najmi, S. B., Hashemipour, M., Maracy, M. R., Hovsepian, S., & Ghasemi, M. (2013) · PubMed Central · Cited by 18
Situação atual da triagem neonatal para hipotireoidismo congênito: críticas e perspectivas
Nascimento, M. L. (2011) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302011000800005 · Cited by 25
Quality performance of newborn screening systems: Strategies for improvement
WEBSTER, D. R. (2007) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-007-0639-2 · Cited by 17
“TSH following abnormally low thyroxine in screening for congenital hypothyroidism (CH) is used in many programmes including those in the Netherlands and some states of the USA.”
BackgroundInfluentialvan der Sluijs Veer, L., Kempers, M. J., Maurice-Stam, H., Last, B. F., Vulsma, T., & Grootenhuis, M. A. (2012) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/1753-2000-6-32 · Cited by 16
Self-citationIntelligence Quotient at the Age of Six years of Iranian Children with Congenital Hypothyroidism
Rahmani, K., Yarahmadi, S., Etemad, K., Mehrabi, Y., Aghang, N., Koosha, A., & Soori, H. (2017) · Indian Pediatrics · doi:10.1007/s13312-018-1243-2 · Cited by 19
“Our results are also consistent with the study of cognitive and motor outcome of early treatment of 82 Dutch CH patients [16], where patients with severe CH had lower verbal, performance, and full-scale IQs than the normative population, whereas IQ scores of patients with moderate and mild CH were comparable to those…”
ResultDisorders of the thyroid in the newborn and infant
Vliet, G. V., & Deladoëy, J. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00016-0 · Cited by 18
Baysal, B. T., Baysal, B., Genel, F., Erdur, B., Özbek, E., Demir, K., & Özkan, B. (2017) · Indian Pediatrics · doi:10.1007/s13312-017-1111-5 · Cited by 15
“The severity of CH has been reported to be associated with neurodevelopmental impairment in patients diagnosed by neonatal screening program [10,11].”
BackgroundHa, E. K., Kim, J. H., Cha, H. R., Lee, G. C., Shin, J., Lee, E., Lee, W. S., Yoo, E.-G., Jung, M. K., & Han, M. Y. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad364 · Cited by 14
Cognitive outcomes for congenital hypothyroid and healthy children: a comparative study.
Ordooei, M., Mottaghipisheh, H., Fallah, R., & Rabiee, A. (2014) · Iranian journal of child neurology. · doi:10.22037/ijcn.v8i4.4804 · Cited by 17
Ünüvar, T., Demir, K., Abacı, A., Ataş, A., Büyükgebiz, A., & Böber, E. (2013) · PubMed · Cited by 13
Lamônica, D. A. C., Anastácio-Pessan, F. D. L., Ferraz, P. M. D. P., & Ribeiro, C. D. C. (2020) · CoDAS · doi:10.1590/2317-1782/20192019017 · Cited by 13
Kucharská, A., Beń‐Skowronek, I., Walczak, M., Ołtarzewski, M., Szalecki, M., Jackowska, T., Lewiñski, A., & Bossowski, A. T. (2016) · Endokrynologia Polska · doi:10.5603/ep.2016.0062 · Cited by 11
van Tijn, D. A., de Vijlder, J. J. M., & Vulsma, T. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0492 · Cited by 11
Self-citationThyroid disease in newborns, infants, and children
van Trotsenburg, A. S. P., & Vulsma, T. (2011) · doi:10.1093/med/9780199235292.003.3273 · Cited by 10
Self-citationde Andrade, J. E., Dias, V. M. A., de Paula, J. J., & Silva, I. N. (2021) · Child Neuropsychology · doi:10.1080/09297049.2021.1876010 · Cited by 9
“FT4 levels prior to treatment, a surrogate marker of severity, are the best predictors of cognitive skills achievement when compared to the age at the beginning of the treatment and FT4 levels at the moment of neuropsychological evaluation (Kempers et al., 2007; Leneman et al., 2001).”
BackgroundResultRazón-Hernández, K. C., Brizuela, N. O., Peraza, A. V., Mendoza, E. O., Rodríguez–Serrano, L. M., Pacheco-Rosado, J., Mejía, G. B., & Sánchez-Huerta, K. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11123427 · Cited by 11
“Several authors have shown that patients with severe CH have lower scores in full-scale, verbal, and performance IQ than patients with moderate or mild CH as measured in preschool [65,103], school [34,55,60], and early adulthood [49].”
BackgroundTenreiro, A. M. P., & Díaz-Guardiola, P. (2010) · HORMONES · doi:10.14310/horm.2002.1268 · Cited by 9
Léger, J., Forhan, A., Dos Santos, S., Larroque, B., Ecosse, E., Charles, M.-A., & Heude, B. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0855 · Cited by 8
Disorders of the Thyroid in the Newborn and Infant
Deladoëy, J., Oettingen, J. E. V., & Vliet, G. V. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00008-7 · Cited by 8
van Trotsenburg, A. S. P., Stoupa, A., Léger, J., Rohrer, T. R., Peters, C. J., Fugazzola, L., Cassio, A., Heinrichs, C., Beauloye, V., Pohlenz, J., et al. (2021) · Yearbook of pediatric endocrinology · doi:10.1530/ey.18.3.8 · Cited by 9
Yarahmadi, S., Tabibi, S. J., Alimohammadzadeh, K., Ainy, E., Gooya, M. M., Mojarrad, M., & Delgoshaei, B. (2010) · Intern J Endocrinol Metab · Cited by 8
Thyroid hormone signaling in the hypothalamus
Alkemade, A., Visser, T. J., & Fliers, E. (2008) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32830eb887 · Cited by 8
Danner, E., Niuro, L., Lapinoja, S., Huopio, H., Viikari, L. A., Kero, J. T., Jääskeläinen, J., & Niinikoski, H. (2024) · Acta Paediatrica · doi:10.1111/apa.17479 · Cited by 7
Neuro-developmental deficits in early-treated congenital hypothyroidism.
Joseph, R. (2008) · PubMed · Cited by 10
Korada, M., Kibirige, M. S., Turner, S. J., Day, J., Johnstone, H., & Cheetham, T. D. (2008) · Journal of Medical Screening · doi:10.1258/jms.2008.007080 · Cited by 7
Cognitive outcome of 458 children over 25 years of neonatal screening for congenital hypothyroidism
Pelaez, J. M., RAMOS, J. C. R. R., Domingos, M. T., de Lima, M. R., Kraemer, G., Cardoso-Demartini, A. D. A., Pereira, R. M., de Lacerda, L., & Nesi-França, S. (2023) · Jornal de Pediatria · doi:10.1016/j.jped.2023.03.003 · Cited by 6
Razavi, Z., Dalili, S., Sabzehei, M. K., Yousefi, A., Nouri, S., Abedi, M., & Bazmamoun, H. (2019) · Iranian journal of child neurology. · doi:10.22037/ijcn.v13i2.18475 · Cited by 8
Quality of life and socioeconomic and educational status in patients with congenital hypothyroidism
Danner, E., Sund, R., Sintonen, H., Niuro, L., Niinikoski, H., Huopio, H., Viikari, L. A., & Jääskeläinen, J. (2024) · Pediatric Research · doi:10.1038/s41390-024-03170-y · Cited by 4
“– 29 Another open question is the effect of a chronic disease per se on the quality of life with regular hospital visits, repeated laboratory tests and possible anxiety of parents.”
BackgroundRomero, M. A., Goto, M. M. F., d'Ouro, M. P. C., Lima, M. C. M. P., Dutra, V. F., Mendes-dos-Santos, C. T., & Santos, D. C. C. (2024) · Jornal de Pediatria · doi:10.1016/j.jped.2024.08.008 · Cited by 4
“7,8 In the present fi ndings, the authors discovered that the association of GREATER RISK for development delay based on the age of treatment initiation was also directly related to the severity of CH since 80.8% of infants with TSH levels greater than 30 m UI/L comprised the group of infants with…”
InfluentialImportância do fonoaudiólogo no acompanhamento de indivíduos com hipotireoidismo congênito
Gejão, M. G., Ferreira, A. T., & Lamônica, D. A. C. (2008) · Revista CEFAC · doi:10.1590/s1516-18462008000300003 · Cited by 4
Cosmo, C. D., & Tonacchera, M. (2018) · Endocrinology · doi:10.1007/978-3-319-45013-1_11 · Cited by 4
Evaluation of Transient or Permanent Congenital Hypothyroidism
Kurtoğlu, S., Baştuğ, O., & Özdemir, A. (2023) · Journal of Clinical Practice and Research · doi:10.14744/cpr.2023.32042 · Cited by 4
Thyroid dysfunction in premature infants
Hong, K. B., Park, J. Y., Chang, Y. P., & Yu, J. (2009) · Korean Journal of Pediatrics · doi:10.3345/kjp.2009.52.9.991 · Cited by 3
Kubicky, R. A., Weiner, E., Carlson, B., & Luca, F. D. (2012) · Case Reports in Endocrinology · doi:10.1155/2012/841947 · Cited by 3
Jacob, J. J. (2016) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2016.12.02.99 · Cited by 4
RAMOS, J. C. R. R., Pelaez, J. M., Ono, S. E., Ramos, C. S., Neto, A. D. C., de Lacerda, L., & Nesi-França, S. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad391 · Cited by 2
Persani, L., Brabant, G. E., Dattani, M., Bonomi, M., Feldt‐Rasmussen, U., Fliers, E., Grüters, A., Maiter, D. M., Schoenmakers, N. A., & van Trotsenburg, A. S. P. (2019) · Yearbook of pediatric endocrinology · doi:10.1530/ey.16.3.16 · Cited by 1
The treatment and monitoring of the therapy of congenital hypothyroidism
Kucharská, A., Beń‐Skowronek, I., Walczak, M., Petriczko, E., Jackowska, T., Lewiñski, A., & Bossowsk, A. (2016) · Pediatric Endocrinology · doi:10.18544/ep-01.15.02.1645 · Cited by 1
Fetal and Postnatal Disorders of Thyroid Function
Lawrence, S. E., Oettingen, J. E. V., & Deladoëy, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814823-5.00044-1 · Cited by 2
Neugeborenenscreening auf Endokrinopathien
Zabransky, S. (2009) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-009-2043-5
Neurodevelopmental Outcomes in Children with Congenital Hypothyroidism
Salerno, M., Martino, L. D., & Cerbone, M. (2015) · Springer eBooks · doi:10.1007/978-3-319-19213-0_12
“Several studies on children and adults with CH detected by neonatal screening reported decreased motor skills with fi ne motor and balance function impairment with respect to controls, more pronounced in children with severe CH at diagnosis [ 38 – 40 ].”
BackgroundAnastácio-Pessan, F. D. L., & Lamônica, D. A. C. (2014) · Revista CEFAC · doi:10.1590/1982-0216201412213 · Cited by 4
Muller, C. E. (2012) · Journal of Laboratory Medicine · doi:10.1515/jlm-2011-0007
Anastácio-Pessan, F. D. L. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.25.2016.tde-26042016-111254
3 Pathophysiology and Diagnosis of Central Hypothyroidism.
Yamada, M., & Mori, M. (2010) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.99.720
Qualität der medizinischen Versorgung von Kindern mit primärer angeborener Hypothyreose
Hoppmann, J., Vasilakis, I., Vogel, M., Stoll, S., Gesing, J. K., Gausche, R., Kratzsch, J., Körner, A., Pfäffle, R. W., & Kiess, W. (2019) · Kinder- und Jugendmedizin · doi:10.1055/a-0854-8933
“[30] Kempers MJ, van der Sluijs Veer L, Nijhuis-van der Sanden RW et al.”
BackgroundROVET, J. F., Foley, T. P., & Nakhla, M. M. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-4745-2.00010-9 · Cited by 1
Kumar, A., Joshi, S., & Ojha, S. (2020) · Journal of Evidence Based Medicine and Healthcare · doi:10.18410/jebmh/2020/253
Cognitive and Behavioral Complications of Congenital Hypothyroidism
Nass, R. D. (2010) · Oxford University Press eBooks · doi:10.1093/oso/9780195342680.003.0016
Desenvolvimento neuropsicomotor de lactentes com hipotireoidismo congênito
do Ouro, M. P. C. (2016) · doi:10.47749/t/unicamp.2016.979549
Molas, J. (1999) · Serra d'Or
van Trotsenburg, A. S. P., & Zwaveling‐Soonawala, N. (2022) · doi:10.1093/med/9780198870197.003.0174
Cosmo, C. D., & Tonacchera, M. (2018) · Endocrinology · doi:10.1007/978-3-319-29195-6_11-1
Rehman, B., Arif, M., Akbar, A., Mazhar, N., Hoodbhoy, Z. A., Memon, F., Sagri, M. N., Zahid, S., Majid, H., Faqiruddin, F., et al. (2026) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70296
“In a Dutch cohort, patients with severe CH had lower full-scale (93.7), verbal (94.9) and performance (93.9) IQ scores, with significant motor problems across all severity subgroups [27].”
Influential
Metadata
- Authors
- Kempers, M. J. E., van der Sluijs Veer, L., Nijhuis-van der Sanden, R. W. G., Lanting, C. I., Kooistra, L., Wiedijk, B. M., Last, B. F., de Vijlder, J. J. M., Grootenhuis, M. A., & Vulsma, T.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- Pediatric Psychology (L.v.d.S.V., B.F.L., M.A.G.), 1100 DE Amsterdam, The Netherlands
- Department of Pediatric Physical Therapy (R.W.G.N.-v.d.S.), Radboud University, Nijmegen Medical Center, 6525 GA Nijmegen, The Netherlands
- Netherlands Organisation for Applied Scientific Research (NL)
- Alberta Children's Hospital (CA)
- Emma Children’s Hospital Academic Medical Center, University of Amsterdam, Departments of Pediatric Endocrinology (M.J.E.K., B.M.W., J.J.M.d.V., T.V.), 1100 DE Amsterdam, The Netherlands
- Corresponding author
- Kempers, Marlies J. E.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2007-03-01
- Volume
- 92
- Issue
- 3
- Pages
- 919-924
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2162302380
- Cited by
- 85
- References
- 15
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 4 · 2022: 4 · 2021: 4 · 2020: 4 · 2019: 5 · 2018: 5 · 2017: 5 · 2016: 7 · 2015: 3 · 2014: 5 · 2013: 5 · 2012: 5
- FWCI
- 2.96
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- VU Research Portal (publishedVersion, other-oa)
- TNO Repository (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Repository hosted by TU Delft Library (TU Delft) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Keywords
- congenital hypothyroidism, newborn screening, cognitive outcomes, motor outcome, IQ, age at treatment initiation, disease severity, long-term follow-up
- MeSH terms
- Child, Congenital Hypothyroidism, Female, Follow-Up Studies, Humans, Infant, Newborn, Intelligence, Male, Motor Skills, Netherlands, Thyroxine, Time Factors, Cohort Studies, Neonatal Screening
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.